Study of a pain drug for severe cancer pain
Part of Mental health, Pain clinical trials.
This trial tests a sustained-release tablet (oxycodone/naloxone) for cancer patients with severe pain and constipation caused by opioids. It aims to see how well the drug works in real-world conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have advanced cancer confirmed by a biopsy or pathology report.
- You have severe cancer pain (score 7 or higher on a 0-10 pain scale) and need regular opioid pain medicine.
- You have opioid-induced constipation (diagnosed by your doctor) that bothers you (score 30 or more on the constipation scale).
- You are expected to live more than 3 months.
- You are willing to sign a consent form and your doctor agrees the study drug is right for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well naldemedine (and certain other constipation medicines) lower the risk of major heart problems in people who take opioids for constipation. It compares medicine use patterns in people with opioid-induced constipation to see who has fewer serious heart events.
This Phase 2 study tests a new medicine (3D1002) taken together with extended-release oxycodone to improve moderate to severe cancer pain. You may be considered if your cancer pain is stable and you can follow the study’s strict pain-medication rules.
This trial tests whether naldemedine, a medication for constipation, can help cancer patients who have constipation caused by opioids. It looks at how well it works and how patients feel.
This study tests whether starting a bowel-prevention approach can help stop constipation caused by opioid pain medicines in people with advanced (metastatic) cancer. You may be able to join if you are about to start long-acting or skin opioid pain treatment.
This study tests a traditional Chinese medicine treatment for constipation caused by opioid pain medications in cancer patients. The goal is to help people on long-term opioid therapy have more regular bowel movements without increasing laxative use.
This trial tests if adding non-opioid pain relievers (like dipyrone or ibuprofen) to opioid therapy can better manage cancer pain. It may help patients whose pain is not well controlled with opioids alone.
Hear when a new Opioid-Induced Constipation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.